https://doi.org/10.3389/fphar.2020.540479
H
Hongye He
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
44
Papers
668
Citations
14
h-index
21
i10-index
Hongye He is an academic researcher from Central South University. The author has contributed to research in topics: Nanoplatforms for cancer theranostics & Cancer Immunotherapy and Biomarkers & Cancer survivorship and care. The author has an h-index of 14, co-authored 38 publications.
Papers by this author
worksGastrin Attenuates Renal Ischemia/Reperfusion Injury by a PI3K/Akt/Bad-Mediated Anti-apoptosis Signaling
2020 · Frontiers in Pharmacology · 93 citations
Biomimetic nanoprobe-augmented triple therapy with photothermal, sonodynamic and checkpoint blockade inhibits tumor growth and metastasis
2022 · Journal of Nanobiotechnology · 47 citations
https://doi.org/10.1186/s12951-022-01287-y
Inhibition of autophagy with Chloroquine enhanced apoptosis induced by 5-aminolevulinic acid-photodynamic therapy in secondary hyperparathyroidism primary cells and organoids
2021 · Biomedicine & Pharmacotherapy · 20 citations
https://doi.org/10.1016/j.biopha.2021.111994
METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2—breast cancer
2023 · Breast Cancer Research · 20 citations
https://doi.org/10.1186/s13058-022-01598-w
Construction and validation of a risk prediction model for clinical axillary lymph node metastasis in T1–2 breast cancer
2022 · Scientific Reports · 10 citations
https://doi.org/10.1038/s41598-021-04495-y
Chemotherapy significantly improves long-term survival of small lesion node negative metaplastic breast carcinoma in T1c population rather than T1a and T1b
2022 · Scientific Reports · 9 citations
https://doi.org/10.1038/s41598-022-04946-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat